Carisma Therapeutics Inc. — Director's Dealing 2020

Feb 26, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sesen Bio, Inc. (SESN)
CIK: 0001485003
Period of Report: 2020-02-24

Reporting Person: Bourdow Carrie L. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-24	Stock Option	$0.8224	A	118000	Acquired	2030-02-24	Common Stock (118000.0)	Direct

Footnotes

F1: The option was granted on February 24, 2020 and vests monthly in equal amounts over a three-year period following the grant date.